ReviewACS biomaterials science & engineering2026
Enhancing Peptide Hydrophilicity of SPPS-Derived Peptides Using Fmoc Noncanonical Amino Acids: A Review.
Review in ACS biomaterials science & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poor peptide solubility in water remains a major challenge in both peptide synthesis and downstream biomedical applications. Recent advances in 9-fluorenylmethoxycarbonyl (Fmoc) noncanonical amino acids (ncAAs) enable rational side-chain design to enhance peptide hydrophilicity derived from solid-phase peptide synthesis (SPPS). This review discusses four major classes of ncAAs, cationic, anionic, polar nonionic, and zwitterionic, each improving water solubility through mechanisms such as charge introduction, charge balancing, and strong hydration. Together, these advances demonstrate how ncAAs can be strategically integrated through side-chain engineering in SPPS to produce more water-soluble peptides. Challenges, including side-chain stability and steric hindrance, as well as the need for efficient postassembly conjugation strategies, highlight the need for continued molecular and synthetic innovation, creating opportunities to integrate Fmoc-ncAAs into synthetic peptides for next-generation soluble peptidic biomaterials with broad biomedical impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.